3rd Feb 2020 11:55 am |
RNS |
Director Dealings / Market Share Purchase |
22nd Jan 2020 12:11 pm |
RNS |
Block listing Application |
7th Jan 2020 10:17 am |
RNS |
Block Listing Return |
2nd Jan 2020 11:41 am |
RNS |
Total Voting Rights |
19th Dec 2019 3:27 pm |
RNS |
Director Dealings / Market Share Purchase |
19th Dec 2019 7:00 am |
RNS |
Extension of Commercial Supply Agreement |
2nd Dec 2019 9:31 am |
RNS |
Total Voting Rights |
27th Nov 2019 10:05 am |
RNS |
Director Dealings / Market Share Purchase |
13th Nov 2019 4:41 pm |
RNS |
Holding(s) in Company |
1st Nov 2019 9:25 am |
RNS |
Total Voting Rights |
28th Oct 2019 12:30 pm |
RNS |
Director Dealings / Market Share Purchase |
23rd Oct 2019 7:00 am |
RNS |
Holding(s) in Company |
23rd Oct 2019 7:00 am |
RNS |
Holding(s) in Company |
16th Oct 2019 7:30 am |
EQS |
Hardman & Co Research: Oxford BioMedica (OXB): Demanding second half |
1st Oct 2019 10:18 am |
RNS |
Total Voting Rights |
25th Sep 2019 11:41 am |
RNS |
Director Dealings / Market Share Purchase |
16th Sep 2019 11:18 am |
RNS |
Director/PDMR Shareholding |
16th Sep 2019 9:15 am |
RNS |
Directors Dealings / Market Share Purchases |
13th Sep 2019 2:57 pm |
RNS |
Long Term Incentive Plan Option Grant |
13th Sep 2019 1:13 pm |
RNS |
Directors Dealings / Market Share Purchases |
13th Sep 2019 10:53 am |
RNS |
Director Dealings / Market Share Purchase |
4th Sep 2019 7:00 am |
RNS |
Oxford Biomedica Interim Results |
2nd Sep 2019 9:31 am |
RNS |
Total Voting Rights |
23rd Aug 2019 11:06 am |
RNS |
Director Dealings / Market Share Purchase |
9th Aug 2019 12:00 pm |
RNS |
Notice of Interim Results |
1st Aug 2019 9:18 am |
RNS |
Total Voting Rights |
25th Jul 2019 2:17 pm |
RNS |
Director Dealings / Market Share Purchase |
1st Jul 2019 11:04 am |
EQS |
Hardman & Co Research: Oxford BioMedica (OXB): Eying up long-term value |
1st Jul 2019 10:01 am |
RNS |
Block listing Interim Review |
1st Jul 2019 9:32 am |
RNS |
Total Voting Rights |
28th Jun 2019 7:00 am |
RNS |
Repayment of Debt Facility |
26th Jun 2019 2:52 pm |
RNS |
Director Dealings / Market Share Purchase |
26th Jun 2019 7:00 am |
RNS |
OXB and Santen enter R&D collaboration |
25th Jun 2019 7:00 am |
RNS |
Board Change |
18th Jun 2019 7:15 am |
EQS |
Hardman & Co Research: Oxford BioMedica (OXB): De-leveraging the balance sheet |
10th Jun 2019 2:34 pm |
RNS |
Director/PDMR Shareholding |
6th Jun 2019 1:08 pm |
RNS |
Axovant update on 1st cohort of Sunrise-PD trial |
6th Jun 2019 11:39 am |
RNS |
Holding(s) in Company |
5th Jun 2019 12:06 pm |
RNS |
Holdings in Company |
4th Jun 2019 5:38 pm |
RNS |
Holdings in Company |